This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
GLOSSARY
- ALS=
- amyotrophic lateral sclerosis;
- BMP=
- bone morphogenic protein;
- CMT=
- Charcot-Marie-Tooth;
- CMT2=
- Charcot-Marie-Tooth type II;
- COP=
- coat complex;
- dHMN=
- distal hereditary motor neuronopathy;
- ER=
- endoplasmic reticulum;
- ERGIC=
- endoplasmic reticulum–Golgi complex intermediate compartment;
- ESCRT=
- endosomal sorting complex required for transport;
- GTPase=
- guanidine triphosphatase;
- HAP=
- huntingtin-associated protein;
- HSAN=
- hereditary sensory and autonomic neuropathy;
- HSP=
- hereditary spastic paraplegia;
- MFN2=
- mitofusin 2;
- MVB=
- multivesicular body;
- PI=
- phosphoinositide;
- REEP=
- receptor-expression-enhancing protein;
- RTN=
- reticulon;
- SNARE=
- soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor;
- TGN=
- trans-Golgi network;
- VAMP=
- vesicle associated membrane protein;
- VAPB=
- vesicle-associated membrane protein-associated protein B.
Normal neural function depends on the appropriate delivery and removal of proteins and lipids at pre-, post- or extrasynaptic membranes. The membrane transport system comprises the endoplasmic reticulum (ER), the Golgi complex, secretory vesicles, endosomes, and lysosomes. This system is involved in 2 fundamental cellular pathways, the secretory and the endocytic pathway. The secretory pathway transports most of the transmembrane and secreted proteins from their site of synthesis in the ER to their final destinations, including the presynaptic membrane. Endocytosis participates in control of the composition of the plasma membrane, intra- and intercellular signaling, and uptake of essential nutrients. Vesicular trafficking along the secretory and endocytic pathways depends on interactions of several membrane proteins with the cytoskeleton. The directionality and specificity of membrane trafficking depends on a large number of transmembrane, cytoskeletal, and adaptor proteins that are involved in membrane shaping and remodeling, and in vesicular trafficking along microtubules. Mutations affecting many of these proteins manifest with different phenotypes, including hereditary spastic paraplegia (HSP), distal hereditary motor neuronopathy (dHMN), Charcot-Marie-Tooth type II (CMT2) neuropathy, and hereditary sensory and autonomic neuropathy (HSAN). The mechanisms of membrane trafficking, secretory pathways, and endocytosis, and their clinical correlations have been recently reviewed.1,–,13
GENERAL MECHANISMS OF MEMBRANE TRAFFICKING
Membrane trafficking involves several common mechanisms, including vesicular biogenesis, transport along microtubules, and tethering and fusion of the vesicle membrane with the recipient compartment (figure).
The secretory pathway proteins from their site of synthesis in the endoplasmic reticulum (ER) to the Golgi complex and from there to their final destinations in the membrane or synaptic vesicles. ER structure depends of interactions of several interacting membrane proteins, including atlastatin-1, receptor-expression-enhancing protein1 (REEP), and spastin, which also …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
